BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 29572615)

  • 1. Precision Medicine for CRC Patients in the Veteran Population: State-of-the-Art, Challenges and Research Directions.
    Mohapatra SS; Batra SK; Bharadwaj S; Bouvet M; Cosman B; Goel A; Jogunoori W; Kelley MJ; Mishra L; Mishra B; Mohapatra S; Patel B; Pisegna JR; Raufman JP; Rao S; Roy H; Scheuner M; Singh S; Vidyarthi G; White J
    Dig Dis Sci; 2018 May; 63(5):1123-1138. PubMed ID: 29572615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mass spectrometry based translational proteomics for biomarker discovery and application in colorectal cancer.
    Ma H; Chen G; Guo M
    Proteomics Clin Appl; 2016 Apr; 10(4):503-15. PubMed ID: 26616366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in colorectal cancer genomics and transcriptomics drive early detection and prevention.
    Lam KK; Thean LF; Cheah PY
    Int J Biochem Cell Biol; 2021 Aug; 137():106032. PubMed ID: 34182137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarker discovery by proteomics-based approaches for early detection and personalized medicine in colorectal cancer.
    Corbo C; Cevenini A; Salvatore F
    Proteomics Clin Appl; 2017 May; 11(5-6):. PubMed ID: 28019089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From Omic Layers to Personalized Medicine in Colorectal Cancer: The Road Ahead.
    Romero-Garmendia I; Garcia-Etxebarria K
    Genes (Basel); 2023 Jul; 14(7):. PubMed ID: 37510334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical applications of next-generation sequencing in colorectal cancers.
    Kim TM; Lee SH; Chung YJ
    World J Gastroenterol; 2013 Oct; 19(40):6784-93. PubMed ID: 24187453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Precision medicine in colorectal cancer: Leveraging multi-omics, spatial omics, and artificial intelligence.
    Xu Z; Li W; Dong X; Chen Y; Zhang D; Wang J; Zhou L; He G
    Clin Chim Acta; 2024 Jun; 559():119686. PubMed ID: 38663471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Actionable Potentials of Less Frequently Mutated Genes in Colorectal Cancer and Their Roles in Precision Medicine.
    Mohd Yunos RI; Ab Mutalib NS; Tieng FYF; Abu N; Jamal R
    Biomolecules; 2020 Mar; 10(3):. PubMed ID: 32245111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic and epigenomic biomarkers in colorectal cancer: From diagnosis to therapy.
    Ruiz-BaƱobre J; Goel A
    Adv Cancer Res; 2021; 151():231-304. PubMed ID: 34148615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Testing for the Treatment of Advanced Colorectal Cancer: An Overview.
    Lin PS; Semrad TJ
    Methods Mol Biol; 2018; 1765():281-297. PubMed ID: 29589315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Targets in Precision Chemoprevention of Colorectal Cancer: An Update from Pre-Clinical to Clinical Trials.
    Yarla NS; Madka V; Pathuri G; Rao CV
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33348563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarker-guided therapy for colorectal cancer: strength in complexity.
    Sveen A; Kopetz S; Lothe RA
    Nat Rev Clin Oncol; 2020 Jan; 17(1):11-32. PubMed ID: 31289352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Personalized treatment for patients with colorectal cancer: role of biomarkers.
    Duffy MJ
    Biomark Med; 2015; 9(4):337-47. PubMed ID: 25808438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards personalized medicine of colorectal cancer.
    Aziz MA; Yousef Z; Saleh AM; Mohammad S; Al Knawy B
    Crit Rev Oncol Hematol; 2017 Oct; 118():70-78. PubMed ID: 28917272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive and prognostic biomarkers in colorectal cancer: A systematic review of recent advances and challenges.
    Das V; Kalita J; Pal M
    Biomed Pharmacother; 2017 Mar; 87():8-19. PubMed ID: 28040600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Diagnostic Biomarkers in Colorectal Cancer.
    Zygulska AL; Pierzchalski P
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Genomic Analysis Workflow for Colorectal Cancer Precision Oncology.
    Corti G; Bartolini A; Crisafulli G; Novara L; Rospo G; Montone M; Negrino C; Mussolin B; Buscarino M; Isella C; Barault L; Siravegna G; Siena S; Marsoni S; Di Nicolantonio F; Medico E; Bardelli A
    Clin Colorectal Cancer; 2019 Jun; 18(2):91-101.e3. PubMed ID: 30981604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From tumour heterogeneity to advances in precision treatment of colorectal cancer.
    Punt CJ; Koopman M; Vermeulen L
    Nat Rev Clin Oncol; 2017 Apr; 14(4):235-246. PubMed ID: 27922044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Family History and Genetic Testing to Determine Risk of Colorectal Cancer.
    Kastrinos F; Samadder NJ; Burt RW
    Gastroenterology; 2020 Jan; 158(2):389-403. PubMed ID: 31759928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular subtyping of colorectal cancer: Recent progress, new challenges and emerging opportunities.
    Wang W; Kandimalla R; Huang H; Zhu L; Li Y; Gao F; Goel A; Wang X
    Semin Cancer Biol; 2019 Apr; 55():37-52. PubMed ID: 29775690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.